Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the Company's participation at the Barclays Global Healthcare Conference to be held at the Loews Miami Hotel in Miami Beach, FL, March 10-13, 2014.
Marcy Graham, Ambit's Executive Director of Investor Relations, will provide an overview of the Company and its lead drug candidate, quizartinib, at 9:00 a.m. ET on Wednesday, March 12, 2014, followed by a breakout session at 9:30am. The presentation will be webcast live through the "Investors & Media" section of the Ambit website at www.ambitbio.com. An audio replay will be available until April 1, 2014 following the initial presentation webcast.
From potential to practice: A blueprint for responsible AI in healthcare